Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence The course of illness in children with steroid-sensitive nephrotic syndrome

Kidney International

Volumn 87, Issue 1, 2015, Pages 217-224

  Sinha, Aditi ^a   Saha, Abhijeet ^b   Kumar, Manish ^c   Sharma, Sonia ^a   Afzal, Kamran ^d   Mehta, Amarjeet ^e   Kalaivani, Mani ^a   Hari, Pankaj ^a   Bagga, Arvind ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

^c Chacha Nehru Bal Chikitsalaya ^*  (India)

^d ALIGARH MUSLIM UNIVERSITY   (India)

^e SMS MEDICAL COLLEGE   (India)

Author keywords

Corticosteroid; Idiopathic nephrotic syndrome; Minimal change; Prednisone; Randomized controlled trial

Indexed keywords

AMLODIPINE; CYCLOPHOSPHAMIDE; ENALAPRIL; LEVAMISOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISOLONE; TACROLIMUS; GLUCOCORTICOID;

ARTICLE; CHILD; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; INDIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK ASSESSMENT; RISK REDUCTION; TREATMENT DURATION; DOUBLE BLIND PROCEDURE; INFANT; NEPHROTIC SYNDROME; PRESCHOOL CHILD; RECURRENT DISEASE; TIME FACTOR; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; NEPHROTIC SYNDROME; PREDNISOLONE; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84920186807     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.240     Document Type: Article

References (26)

1. Tarshish P, Tobin JN, Bernstein J et al. Prognostic significance of The early course of minimal change nephrotic syndrome: Report of The International Study of Kidney Disease in Children. J Am Soc Nephrol 1997; 8: 769-776.
2. Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2007; 4: CD001533.
3. Jayantha UK. Comparison of ISKDC regime with a six month steroid regime in The treatment of steroid sensitive nephrotic syndrome [abstract]. 7th Asian Congress of Pediatric Nephrology, Singapore, 2000, Nov 1-4.
4. Ehrich JH, Brodehl J. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr 1993; 152: 357-361.
5. Ueda N, Chihara M, Kawaguchi S et al. Intermittent vs. long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome. J Pediatr 1998; 112: 122-126.
6. Hiraoka M, Tsukahara H, Haruki S et al. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children. Kidney Int 2000; 58: 1247-1252.
7. Kidney Disease Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int 2012; Suppl 2: 139-274.
8. Bagga A, Ali U, Banerjee S et al. Indian Pediatric Nephrology Group. Indian Academy of Pediatrics. Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 2008; 45: 203-214.
9. Hiraoka M, Tsukahara H, Matsubara K et al. West Japan Cooperative Study Group of Kidney Disease in Children. A randomized study of two long course prednisolone regimens for nephrotic syndrome in children. Am J Kidney Dis 2003; 41: 1155-1162.
10. Ksiazek J, Wyszynska T. Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr 1995; 84: 889-893.
11. Gulati S, Ahmed M, Sharma RK et al. Comparison of abrupt withdrawal versus slow tapering regimen of prednisolone therapy in The management of first episode of steroid responsive childhood idio-pathic nephrotic syndrome [abstract]. Nephrol Dialysis Transplant 2001; 16: A87.
12. Pecoraro C, Caropreso MR, Passaro G et al. Therapy of first episode of steroid responsive nephrotic syndrome: a randomized controlled trial [abstract]. Pediatr Nephrol 2004; 19: C72.
13. Teeninga N, Kist-van Holthe J, van Rijskwijk N et al. Extending prednisolone therapy does not reduce relapse in childhood nephrotic syndrome. J Am Soc Nephrol 2012; 24: 149-159.
14. Bagga A, Hari P, Srivastava RN. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome. Pediatr Nephrol 1999; 13: 824-827.
15. Sinha A, Hari P, Sharma PK et al. Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr 2012; 49: 881-887.
16. Kabuki N, Okugawa T, Hayakawa H et al. Influence of age at onset on The outcome of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 1998; 12: 467-470.
17. Mishra OP, Thakur N, Mishra RN et al. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome. J Nephrol 2012; 25: 394-400.
18. Satomura K, Yamaoka K, Shima M et al. Standard vs. low initial dose of prednisolone therapy for first episodes of nephrotic syndrome in children [abstract]. Pediatr Nephrol 2001; 16: C117.
19. Andersen RF, Thrane N, Noergaard K et al. Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome. Pediatr Nephrol 2010; 25: 1299-1304.
20. Takeda A, Matsutani H, Niimura F et al. Risk factors for relapse in childhood nephrotic syndrome. Pediatr Nephrol 1996; 10: 740-741.
21. NFHS-3, 2005-06: India: volume I. Mumbai: International Institute for Population Sciences and Macro International, 2007.
22. Mehls O, Hoyer P. Dosing of glucocorticoids in nephrotic syndrome. Pediatr Nephrol 2011; 26: 2095-2098.
23. Schwartz GJ, Munoz A, Schneider MF et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629-637.
24. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on The diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-576.
25. www.who.int/growthref/tools/en, accessed 31 December 2013.
26. Report of The International Study of Kidney Disease in Children. Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of The International Study of Kidney Disease in Children. J Pediatr 1982; 101: 514-518.